ECSP22081230A - Tratamientos con radiación ultravioleta - Google Patents

Tratamientos con radiación ultravioleta

Info

Publication number
ECSP22081230A
ECSP22081230A ECSENADI202281230A ECDI202281230A ECSP22081230A EC SP22081230 A ECSP22081230 A EC SP22081230A EC SENADI202281230 A ECSENADI202281230 A EC SENADI202281230A EC DI202281230 A ECDI202281230 A EC DI202281230A EC SP22081230 A ECSP22081230 A EC SP22081230A
Authority
EC
Ecuador
Prior art keywords
ultraviolet radiation
treatments
systems
computer
methods
Prior art date
Application number
ECSENADI202281230A
Other languages
English (en)
Inventor
Migdalia Fort
Marigdalia Ramirez-Fort
Original Assignee
Migdalia Fort
Ramirez Fort Marigdalia Kaleth
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Migdalia Fort, Ramirez Fort Marigdalia Kaleth filed Critical Migdalia Fort
Publication of ECSP22081230A publication Critical patent/ECSP22081230A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N5/0613—Apparatus adapted for a specific treatment
    • A61N5/0624—Apparatus adapted for a specific treatment for eliminating microbes, germs, bacteria on or in the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/48—Other medical applications
    • A61B5/4836—Diagnosis combined with treatment in closed-loop systems or methods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B6/00—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
    • A61B6/02—Arrangements for diagnosis sequentially in different planes; Stereoscopic radiation diagnosis
    • A61B6/03—Computed tomography [CT]
    • A61B6/037—Emission tomography
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N2/00—Magnetotherapy
    • A61N2/004—Magnetotherapy specially adapted for a specific therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N2/00—Magnetotherapy
    • A61N2/004—Magnetotherapy specially adapted for a specific therapy
    • A61N2/006—Magnetotherapy specially adapted for a specific therapy for magnetic stimulation of nerve tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N2/00—Magnetotherapy
    • A61N2/004—Magnetotherapy specially adapted for a specific therapy
    • A61N2/008—Magnetotherapy specially adapted for a specific therapy for pain treatment or analgesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N2/00—Magnetotherapy
    • A61N2/02—Magnetotherapy using magnetic fields produced by coils, including single turn loops or electromagnets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N5/0601—Apparatus for use inside the body
    • A61N5/0603—Apparatus for use inside the body for treatment of body cavities
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N5/0613—Apparatus adapted for a specific treatment
    • A61N5/0616—Skin treatment other than tanning
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
    • A61N5/1001—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy using radiation sources introduced into or applied onto the body; brachytherapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
    • A61N5/1001—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy using radiation sources introduced into or applied onto the body; brachytherapy
    • A61N5/1028—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy using radiation sources introduced into or applied onto the body; brachytherapy using radiation sources applied onto the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
    • A61N5/103—Treatment planning systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
    • A61N5/1048—Monitoring, verifying, controlling systems and methods
    • A61N5/1071—Monitoring, verifying, controlling systems and methods for verifying the dose delivered by the treatment plan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N5/0601—Apparatus for use inside the body
    • A61N2005/0602—Apparatus for use inside the body for treatment of blood vessels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N5/0601—Apparatus for use inside the body
    • A61N5/0603—Apparatus for use inside the body for treatment of body cavities
    • A61N2005/0604—Lungs and/or airways
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N5/0601—Apparatus for use inside the body
    • A61N5/0603—Apparatus for use inside the body for treatment of body cavities
    • A61N2005/0605—Ear
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N5/0601—Apparatus for use inside the body
    • A61N5/0603—Apparatus for use inside the body for treatment of body cavities
    • A61N2005/0606—Mouth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N5/0601—Apparatus for use inside the body
    • A61N5/0603—Apparatus for use inside the body for treatment of body cavities
    • A61N2005/0608—Rectum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N5/0601—Apparatus for use inside the body
    • A61N5/0603—Apparatus for use inside the body for treatment of body cavities
    • A61N2005/0609—Stomach and/or esophagus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N5/0601—Apparatus for use inside the body
    • A61N5/0603—Apparatus for use inside the body for treatment of body cavities
    • A61N2005/0611—Vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N2005/0626—Monitoring, verifying, controlling systems and methods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N2005/0626—Monitoring, verifying, controlling systems and methods
    • A61N2005/0627—Dose monitoring systems and methods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N2005/0658—Radiation therapy using light characterised by the wavelength of light used
    • A61N2005/0661—Radiation therapy using light characterised by the wavelength of light used ultraviolet
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
    • A61N5/103—Treatment planning systems
    • A61N5/1031—Treatment planning systems using a specific method of dose optimization

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Radiology & Medical Imaging (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • Neurology (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Surgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical & Material Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicinal Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • High Energy & Nuclear Physics (AREA)
  • Optics & Photonics (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
  • Radiation-Therapy Devices (AREA)
  • Magnetic Heads (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Manufacture Of Macromolecular Shaped Articles (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Physical Water Treatments (AREA)
  • Treatment Of Water By Oxidation Or Reduction (AREA)
  • External Artificial Organs (AREA)

Abstract

Se proporcionan sistemas, métodos y medios legibles por ordenador para permitir tratamientos con radiación ultravioleta.
ECSENADI202281230A 2020-03-26 2022-10-20 Tratamientos con radiación ultravioleta ECSP22081230A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063000302P 2020-03-26 2020-03-26
US202063040134P 2020-06-17 2020-06-17
US202163161161P 2021-03-15 2021-03-15

Publications (1)

Publication Number Publication Date
ECSP22081230A true ECSP22081230A (es) 2022-11-30

Family

ID=77890741

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSENADI202281230A ECSP22081230A (es) 2020-03-26 2022-10-20 Tratamientos con radiación ultravioleta

Country Status (16)

Country Link
US (2) US11707223B2 (es)
EP (1) EP4126209A4 (es)
JP (1) JP2023519915A (es)
KR (1) KR20230008056A (es)
AU (1) AU2021244617A1 (es)
BR (1) BR112022019335A2 (es)
CA (1) CA3173452A1 (es)
CL (2) CL2022002614A1 (es)
CO (1) CO2022015185A2 (es)
CR (1) CR20220535A (es)
EC (1) ECSP22081230A (es)
GB (1) GB2610074B (es)
IL (1) IL296818A (es)
MX (1) MX2022011984A (es)
PE (1) PE20221858A1 (es)
WO (1) WO2021195586A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11965776B2 (en) * 2021-08-10 2024-04-23 B/E Aerospace, Inc. System and method for quantifying an exposure dose on surfaces
CN117504146B (zh) * 2023-11-07 2024-08-20 中国人民解放军总医院第二医学中心 一种用于进行体内紫外线疗法的uv光输送装置

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2277542B1 (en) * 2001-06-01 2014-04-16 Cornell Research Foundation Inc. Modified antibodies to prostrate-specific membrane antigen and uses thereof
US7514078B2 (en) 2001-06-01 2009-04-07 Cornell Research Foundation, Inc. Methods of treating prostate cancer with anti-prostate specific membrane antigen antibodies
US6960201B2 (en) * 2002-02-11 2005-11-01 Quanticum, Llc Method for the prevention and treatment of skin and nail infections
US8435529B2 (en) * 2002-06-14 2013-05-07 Immunomedics, Inc. Combining radioimmunotherapy and antibody-drug conjugates for improved cancer therapy
US20080131968A1 (en) * 2002-08-28 2008-06-05 Nomir Medical Technologies, Inc. Near-infrared electromagnetic modification of cellular steady-state membrane potentials
WO2007123859A2 (en) * 2006-04-17 2007-11-01 Keraderm Llc Method and device to inactivate and kill cells and organisms that are undesirable
US8815229B2 (en) * 2009-10-12 2014-08-26 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Granulysin in immunotherapy
CN102753194B (zh) * 2009-12-02 2015-07-08 伊麦吉纳博公司 靶向人前列腺特异性膜抗原的j591微抗体和双抗体
US9155908B2 (en) * 2010-06-11 2015-10-13 Koninklijke Philips N.V. Simultaneous multi-modality inverse optimization for radiotherapy treatment planning
JP6025756B2 (ja) * 2011-03-07 2016-11-16 ザ トラスティーズ オブ コロンビア ユニバーシティ イン ザ シティ オブ ニューヨーク 殺菌装置、及び、殺菌装置の作動方法
TWI501601B (zh) * 2011-08-15 2015-09-21 Mediatek Inc 裝置搜尋的處理方法
US9005151B2 (en) * 2011-09-07 2015-04-14 Choon Kee Lee Thermal apparatus
WO2013102051A1 (en) * 2011-12-29 2013-07-04 Board Of Regents, The University Of Texas System Systems and methods for altering mammalian body temperature by targeting glabrous and non-glabrous tissue
WO2013126147A2 (en) * 2012-02-24 2013-08-29 Cornell University Elevated psma identifies lethal prostate cancers
US20140140959A1 (en) 2012-10-05 2014-05-22 Aladar A. Szalay Energy Absorbing-Based Diagnostic and Therapeutic Methods Employing Nucleic Acid Molecules Encoding Chromophore-Producing Enzymes
US10779875B2 (en) 2013-05-06 2020-09-22 Novocure Gmbh Optimizing treatment using TTfields by changing the frequency during the course of long term tumor treatment
WO2015066238A2 (en) * 2013-10-29 2015-05-07 Ultraviolet Interventions Inc. Systems and methods for sterilization using uv light
CN111888514A (zh) * 2015-06-03 2020-11-06 纽约市哥伦比亚大学托管会 选择性地影响和/或杀灭病毒的设备、方法及系统
US10940329B2 (en) * 2016-11-22 2021-03-09 Immunolight, Llc Phosphor-containing drug activator activatable by a Monte Carlo derived x-ray exposure, system containing the activator, and methods for use
US10933134B2 (en) * 2017-03-16 2021-03-02 Memorial Sloan Kettering Cancer Center Combination therapies for treatment of cancer
WO2019194862A2 (en) * 2017-09-29 2019-10-10 The Henry M. Jackson Foundation For The Advancement Of Military Medicine Radioprotectors and electron paramagnetic resonance for determination of cellular resistance to ionizing radiation without radiation exposure
CN111565762A (zh) * 2017-11-10 2020-08-21 威斯康星校友研究基金会 使用靶向放射治疗(trt)来驱动对免疫疗法的抗肿瘤免疫反应
US20210308286A1 (en) * 2018-07-30 2021-10-07 The Johns Hopkins University Long-circulating psma-targeted phototheranostic agent
US10918886B2 (en) 2019-06-10 2021-02-16 Varian Medical Systems, Inc. Flash therapy treatment planning and oncology information system having dose rate prescription and dose rate mapping

Also Published As

Publication number Publication date
GB2610074B (en) 2024-07-10
CO2022015185A2 (es) 2022-11-08
PE20221858A1 (es) 2022-11-30
GB202215137D0 (en) 2022-11-30
US20240100366A1 (en) 2024-03-28
CL2023001516A1 (es) 2024-01-19
GB2610074A (en) 2023-02-22
WO2021195586A1 (en) 2021-09-30
US20230107906A1 (en) 2023-04-06
EP4126209A4 (en) 2024-06-19
US11707223B2 (en) 2023-07-25
EP4126209A1 (en) 2023-02-08
IL296818A (en) 2022-11-01
BR112022019335A2 (pt) 2022-11-29
AU2021244617A1 (en) 2022-11-10
CA3173452A1 (en) 2021-09-30
KR20230008056A (ko) 2023-01-13
CR20220535A (es) 2022-12-15
MX2022011984A (es) 2023-02-01
JP2023519915A (ja) 2023-05-15
CL2022002614A1 (es) 2023-06-09

Similar Documents

Publication Publication Date Title
CO2022015185A2 (es) Tratamientos con radiación ultravioleta
CO2020015255A2 (es) Métodos y composiciones para tratar el cáncer
CL2021001690S1 (es) Estuche para audífonos.
BR112019001737A2 (pt) expressão de pten-long com vírus oncolíticos
AR113862A1 (es) Anticuerpos anti-cd47 y sus usos para tratar cáncer
CO2017002170A2 (es) Terapia de combinación para tratar un paramixovirus
CL2023001550A1 (es) Sistemas activos dinámicos acromosómicos.
CL2018002334A1 (es) Moduladores de complementos factor b (divisional solicitud 201600606)
CL2016001082A1 (es) Proceso para la síntesis de un inhibidor de indolamina 2,3-dioxigenasa
BR112018003269A2 (pt) conjugados de fármaco-anticorpo anti-dll3 e métodos de utilização
CL2018001372A1 (es) Moléculas de anticuerpo contra april y usos de las mismas
CO2018004937A2 (es) Células asesinas naturales y células ilc3 y usos de las mismas
BR112017004444A2 (pt) novos anticorpos anti-mfi2 e métodos de uso
BR112018073238A2 (pt) vírus oncolíticos compreendendo esrage e métodos de tratamento de câncer
BR112018070578A2 (pt) composições, sistemas, kits, e métodos para tratar uma infecção
BR112018076233A2 (pt) métodos e sistemas para propagação baseada em amido para um microrganismo usado em produção bioquímica celulósica
BR112018010279A2 (pt) novos anticorpos anti-emr2 e métodos de uso
CO2017010808A2 (es) Sistemas y métodos para la vigilancia activa del cancer de próstata
UY4891S (es) Calzado
BR112017023969A2 (pt) ?microrganismo do gênero escherichia que produz l-triptofano e um método para produzir l- triptofano com o uso do mesmo?
PE20171673A1 (es) Recubrimiento resistente al cuarteado y metodo del mismo
CL2017002829A1 (es) Sistemas y métodos para reducir las corrientes parásitas no deseadas.
CO2018000171A2 (es) Metodos de purificacion y/o inactividad viral
BR112021019120A2 (pt) Células t específicas para antígenos de múltiplos vírus respiratórios e métodos de produção e uso das mesmas terapeuticamente
DOP2023000155A (es) Tratamiento y terapia de mantenimiento para el cáncer de vejiga con gemcitabina